Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5421]
News [12609]
Articles [172]
Editorials [5]
Conferences [246]
elearning [17]
FORTE trial results: KRd with or without transplantation in newly diagnosed...
Dr Francesca Gay - University Hospital City of Health and Science of Turin...
FORTE trial results: KRd with or without transplantation in newly diagnosed myeloma according to risk status ( Dr Francesca Gay - University Hospital City of Health and Science of Turin, Turin, Italy )
6 Jun 2019
Olaparib and durvalumab in metastatic BRCA wild type triple-negative breast...
Dr Zahi Mitri - OHSU Hospital, Portland, USA
Olaparib and durvalumab in metastatic BRCA wild type triple-negative breast cancer ( Dr Zahi Mitri - OHSU Hospital, Portland, USA )
6 Jun 2019
CASSIOPEIA: Daratumumab plus D-VTd vs VTd in transplant-eligible NDMM
Prof Philippe Moreau - University Hospital of Nantes, Nantes, France
CASSIOPEIA: Daratumumab plus D-VTd vs VTd in transplant-eligible NDMM ( Prof Philippe Moreau - University Hospital of Nantes, Nantes, France )
6 Jun 2019
ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in...
Dr William Tap - Memorial Sloan Kettering Cancer Center, New York, USA
ANNOUNCE: Combination of olaratumab and doxorubicin versus doxorubicin alone in patients with advanced soft tissue sarcomas ( Dr William Tap - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Jun 2019
Clinical activity and tolerability of the RET inhibitor BLUE-667 in patients...
Dr Justin F. Gainor - Massachusetts General Hospital, Boston, USA
Clinical activity and tolerability of the RET inhibitor BLUE-667 in patients with advanced RET fusion and NSCLC ( Dr Justin F. Gainor - Massachusetts General Hospital, Boston, USA )
6 Jun 2019
ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute...
Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
ZUMA-3: A study of KTE-X19 in adults with relapsed/refractory acute lymphoblastic leukaemia ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
6 Jun 2019
Predictive models for treatment risk in cancer
Dr Charlotte Moser - Founder weCancerTALK
Predictive models for treatment risk in cancer ( Dr Charlotte Moser - Founder weCancerTALK )
5 Jun 2019
Better education about breast cancer treatment in Africa
Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International...
Better education about breast cancer treatment in Africa ( Dr Beatrice Wiafe-Addai - Peace And Love Hospital Breast care International, Accra, Ghana )
5 Jun 2019
Barriers to cancer care in Africa
Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es...
Barriers to cancer care in Africa ( Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )
5 Jun 2019
The Global Health Catalyst initiative
Wilfred Ngwa - Harvard Medical School. Boston, Massachusetts
The Global Health Catalyst initiative ( Wilfred Ngwa - Harvard Medical School. Boston, Massachusetts )
5 Jun 2019
The role of cancer surgery in Africa
Riccardo Audisio - Sahlgrenska University Hospital, Gothenburg, Sweden
The role of cancer surgery in Africa ( Riccardo Audisio - Sahlgrenska University Hospital, Gothenburg, Sweden )
5 Jun 2019
A super-fast, cloud-based, AI imaging system for radiotherapy
Mahmudul Hasan - CEO MVision AI, Helsinki, Finland
A super-fast, cloud-based, AI imaging system for radiotherapy ( Mahmudul Hasan - CEO MVision AI, Helsinki, Finland )
5 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation